Publications Committee

Chair:  Ray Harris

The Publications Committee is responsible for coordinating all areas of publishing within PSI.  The Publications Committee meets approximately four times a year, including once face-to-face. We work closely with MCI and, for the Journal, with Wiley.  Each member of the committee has responsibility for an activity, and these activities are: 

Pharmaceutical Statistics                                                     

Pharmaceutical Statistics, the official journal of PSI, tackles real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics.

                                                                      Pharmaceutical Statistics
               


Please consider submitting a paper to the Journal.  Many of the most read and cited papers have been written by industry statisticians so please take a little of your busy time and prepare and submit a paper.  More details can be found here.

SPIN

SPIN is PSI’s quarterly electronic newsletter.  Regular articles include reviews of recent meetings and courses, ‘Grumpy Old Men’ and ‘Desert Island Disc’ articles, a diary of future events, information about changes in membership, letters to the Editor and social news. It is a forum for airing views on current issues and a vehicle for the subcommittees, special interest groups and working parties to report their activities and progress to PSI members.

eNews

Every fortnight eNews is sent to the membership.  This includes PSI news, PSI events, and advertisements.  It is an opportunity to remind the membership of what is going on in PSI and the wider community and to highlight such things as when early bird discounts are about to end.

Pharmaceutical Statistics Journal Club

The Journal Club hosts quarterly 90 min teleconferences, open to PSI members and non-PSI members with no need to pre-register.  Two papers are selected from Pharmaceutical Statistics and authors are invited to present their papers followed by discussion for each paper.  Papers (for a limited time) and slides are available to download beforehand from a public area of the PSI website.  Audio and video recordings of the meetings are available to download from the website after the meeting. For details of future journal club TCs, please visit the journal club page or contact journalclub@psiweb.org.

LinkedIn

Membership to the LinkedIn PSI group is open to all, not just members, and therefore has substantially more members than PSI itself.  It is used to communicate about PSI matters, including, for instance, coming meetings, jobs advertised with PSI, when the Journal is published, etc.  It also offers a very convenient way to discuss statistical topics.

Twitter

PSI has a Twitter account, and, as with LinkedIn, is used it to publicise PSI matters.

Who we are

Sarah Bray

Journal club

Albert Chau

Technical support for Journal Club

Jodie Crawford

SPIN sub-editor

Matthew Gibb

SPIN editor

Ray Harris

Chair and Journal liaison with Wiley

Noormaa Jaumdally

eNews editor

Kevin Kane

Social media

Rhiannon Maudsley

Journal Club and SPIN social editor

Mairead North

Journal Club

Anny Stari

Web news

Laura Steven

Journal Club

 

Latest News


Show all news

EventsFuture Events


  • Expert Working Group on Confidentiality of Interim Results - Dates: 11 May, 2017

    The PSI/EFSPI expert working group on Confidentiality of Interim Results are planning to meet face to face on 11 May.
  • Estimating Sample Sizes in Clinical Trials - Dates: 28 – 29 Jun, 2017

    The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design. The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

GSK logo

Director, Statistics

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...

Astrazeneca

Early Clinical Development – various levels

read more...

LOGO

Biostatistics Head of Department

read more...

Astrazeneca

Principal Statistician – Centralised Statistical Monitoring

read more...

Astrazeneca

Clinical Trial Design Methodology Expert - Statistical Innovation Team

read more...